Food for special medical purpose for cancer patients and related nutrition research progress

Authors

CHEN Yao, Ausnutria Dairy 〔China〕 Co., Ltd., Changsha, Hunan 410200, China;Ausnutria Institute of Food and Nutrition, Changsha, Hunan 410200, China
YUAN Song-mei, Ausnutria Dairy 〔China〕 Co., Ltd., Changsha, Hunan 410200, China;Ausnutria Institute of Food and Nutrition, Changsha, Hunan 410200, China
CAO Ping, Ausnutria Dairy 〔China〕 Co., Ltd., Changsha, Hunan 410200, China;Ausnutria Institute of Food and Nutrition, Changsha, Hunan 410200, China
LIU Xue-cong, Ausnutria Dairy 〔China〕 Co., Ltd., Changsha, Hunan 410200, China;Ausnutria Institute of Food and Nutrition, Changsha, Hunan 410200, China
LI Wei, Ausnutria Dairy 〔China〕 Co., Ltd., Changsha, Hunan 410200, China;Ausnutria Institute of Food and Nutrition, Changsha, Hunan 410200, ChinaFollow

Corresponding Author(s)

李威（1981—），男，澳优乳业（中国）有限公司澳优食品与营养研究院院长。E-mail：wei.li@ausnutria.com

Abstract

This review outlined the regulatory policy and approval progress of food for the special medical purpose （FSMP）, analyzed the development status and the development key point of cancer FSMP. And the recent nutrition research related to cancer FSMP was reviewed.

Publication Date

4-25-2023

First Page

25

Last Page

30,72

DOI

10.13652/j.spjx.1003.5788.2022.60072

Recommended Citation

Yao, CHEN; Song-mei, YUAN; Ping, CAO; Xue-cong, LIU; and Wei, LI (2023) "Food for special medical purpose for cancer patients and related nutrition research progress," Food and Machinery: Vol. 39: Iss. 2, Article 4.
DOI: 10.13652/j.spjx.1003.5788.2022.60072
Available at: https://www.ifoodmm.cn/journal/vol39/iss2/4

References

[1] ZHENG R S, ZHANG S W, ZENG H M, et al. Cancer incidence and mortality in China, 2016[J]. Journal of the National Cancer Center, 2022, 2（1）: 1-9.
[2] 宋春花, 王昆华, 郭增清, 等. 中国常见恶性肿瘤患者营养状况调查[J]. 生命科学, 2020, 50（12）: 1 437-1 452.
[3] 国家卫生和计划生育委员会. 食品安全国家标准 特殊医学用途配方食品通则: GB 29922—2013[S]. 北京: 中国标准出版社, 2013: 1-9.
[4] 韩军花. 中国特殊医学用途配方食品标准法规: 现状及展望[J]. 营养学报, 2017, 39（6）: 543-548.
[5] 陈彬合, 袁振海, 贾婵媛. 我国特殊医学用途配方食品批准情况分析与开发建议[J]. 食品与药品, 2020, 22（4）: 294-300.
[6] 边振甲, 付萍, 孙贵范, 等. 中国特殊食品产业发展蓝皮书[M]. 北京: 中国医药科技出版社, 2021: 242-338.
[7] 韦晓瑜, 聂大可. 关于特殊医学用途配方食品注册管理制度实施的思考[J]. 中国食品卫生杂志, 2022, 34（6）: 1 286-1 290.
[8] WANG Y D, ZHAO T, LIU R J, et al. New perspective toward nutritional support for malnourished cancer patients: Role of lipids[J]. Comprehensive Reviews in Food Science and Food Safety, 2021, 20: 1 381-1 421.
[9] GLIWSKA E, GUZEK D, PRZEKOP Z,et al. Quality of life of cancer patients receiving enteral nutrition: A systematic review of randomized controlled trials[J]. Nutrients, 2021,13（12）: 4 551-4 570.
[10] 曹琳, 王子君. 胃癌术后早期肠内营养的护理[J]. 全科护理, 2015, 15（12）: 1 450-1 451.
[11] 柳硕岩, 陈啸风, 王枫, 等. 食管癌术后不同肠内营养配方的治疗效益[J]. 中华胃肠外科杂志, 2012, 15（5）: 473-475.
[12] 缪明永. 肿瘤患者高代谢及其机制的研究进展[J]. 肿瘤代谢与营养电子杂志, 2022, 9（2）: 168-174.
[13] CAO D X, WU G H, ZHANG B, et al. Resting energy expenditure and body composition in patients with newly detected cancer[J]. Clinical Nutrition, 2010, 29（1）: 72-77.
[14] 陈丽君, 廖欣, 喻金龙, 等. 消化道恶性肿瘤住院患者的能量消耗研究[J]. 肿瘤代谢与营养电子杂志, 2020, 7（4）: 455-459.
[15] 朱文强, 全竹富, 王新颖, 等. 胰腺癌病人静息能量消耗与营养状态关系的研究[J]. 肠外与肠内营养, 2011, 18（4）: 221-224.
[16] 曹冬兴, 张波, 郑烈伟, 等. 恶性肿瘤病人能量消耗及机体组成变化测定[J]. 中国实用外科杂志, 2008, 28（11）: 953-956.
[17] SHINSYU A, BAMBA S, KURIHARA M, et al. Inflammatory cytokines, appetite-regulating hormones, and energy metabolism in patients with gastrointestinal cancer[J]. Oncology Letters, 2020, 20（2）: 1 469-1 479.
[18] BARCELLOS P S, BORGES N, TORRESD P M. Resting energy expenditure in cancer patients: Agreement between predictive equations and indirect calorimetry[J]. Clinical Nutrition ESPEN, 2021, 42（5）: 286-291.
[19] JANN A, PATRICK B, VICKIE B, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clinical Nutrition, 2017, 36（1）: 11-48.
[20] 石汉平, 蔡丽雅. 肿瘤营养代谢调节治疗[J]. 肿瘤综合治疗电子杂志, 2019, 5（1）: 83-86.
[21] BARACOS V E. Skeletal muscle anabolism in patients with advanced cancer[J]. Lancet Oncology, 2015, 16（1）: 13-14.
[22] 王淑安, 王孔成, 汪娟, 等. 蛋白质摄入水平在头颈肿瘤放化疗中的应用研究[J]. 国际放射医学核医学杂志, 2021, 45（2）: 83-87.
[23] 朱仲玲, 阎昭. 肿瘤异常脂肪酸代谢研究进展[J]. 中国肿瘤临床, 2015, 42（5）: 313-316.
[24] 邵郑福, 丁佩剑. 脂质代谢异常在结直肠癌发病中的作用及其相关治疗应用研究进展[J]. 山东医药, 2020, 60（32）: 94-97.
[25] BREITKREUTZ R, TESDAL K, JENTSCHURA D, et al. Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: A randomized controlled study[J]. Wiener Klinische Wochenschrift, 2005, 117（19/20）: 685-692.
[26] ANGELO S, MOTTI M L, MECCARIELLO R. ω-3 and ω-6 polyunsaturated fatty acids, obesity and cancer[J]. Nutrients, 2020, 12（2）: 275.
[27] CARRERA M. Peroxisome proliferator-activated receptors and the control of inflammation update[J]. Medicinal Chemistry Reviews- Online, 2004, 1（3）: 297-298.
[28] ZHAO Y, JOSHI-BARVE S, BARVE S, et al. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation[J]. Journal of the American College of Nutrition, 2004, 23（1）: 71-78.
[29] YANG J, ZHANG X X, LI K, et al. Effects of EN combined with PN enriched with n-3 polyunsaturated fatty acids on immune related indicators and early rehabilitation of patients with gastric cancer: A randomized controlled trial[J]. Clinical Nutrition, 2022, 41（6）: 1 163-1 170.
[30] 詹雅诗. 恶性肿瘤患者糖代谢紊乱的临床分析[D]. 广州: 暨南大学, 2008: 1-72.
[31] 寇卫政, 路平, 杨留中, 等. 146例结直肠癌患者糖代谢紊乱的初步调查分析[J]. 山东医药, 2010, 50（40）: 57-58.
[32] 葛可佑. 中国营养科学全书: 下册[M]. 2版. 北京: 人民卫生出版社, 2019: 1 610-1 622.
[33] CUENCA-MIC O, ACEVES C. Micronutrients and breast cancer progression: A systematic review[J]. Nutrients, 2020, 12（12）: 3 613-3 631.
[34] 汤敏誉, 曾源, 郝哲学, 等. 维生素与矿物质补充剂在肺癌防治中的临床应用[J]. 肿瘤代谢与营养电子杂志, 2020, 7（1）: 117-121.
[35] 梁炜琦, 孙萍, 路云丽. 山西太原地区部分正常人群与肿瘤患者维生素营养状况分析[J]. 现代预防医学, 2021, 48（19）: 3 503-3 508.
[36] SOLOMON L R. Functional vitamin B₁₂ deficiency in advanced malignancy: Implications for the management of neuropathy and neuropathic pain[J]. Supportive Care in Cancer, 2016, 24（8）: 3 489-3 494.
[37] KENNEL K A, DRAKE M T. Vitamin D in the cancer patient[J]. Curr Opin Support Palliat Care, 2013, 7（3）: 272-277.
[38] 李芷君, 时静, 王增亮, 等. 癌症患者维生素D营养状况分析[J]. 中国肺癌杂志, 2021, 24（5）: 345-350.
[39] WANG Y, SUN Z, LI A, et al. Association between serum zinc levels and lung cancer: A meta-analysis of observational studies[J]. World J Surg Oncol, 2019, 17（1）: 78-85.
[40] GRBER U, HOLZHAUER P, KISTERS K, et al. Micronutrients in oncological intervention[J]. Nutrients, 2016, 8（3）: 163-192.
[41] 王斌, 王首寒, 陈佳祺, 等. 不同维生素矿物质比营养干预在全胃切除术围手术期的临床效果分析[J]. 肿瘤代谢与营养电子杂志, 2015, 2（2）: 45-47.
[42] REVUELTA INIESTA R, GERASIMIDIS K, PACIAROTTI I, et al. Micronutrient status influences clinical outcomes of paediatric cancer patients during treatment: A prospective cohort study[J]. Clinical Nutrition, 2021, 40（5）: 2 923-2 935.
[43] KOOLE J L, BOURS M J L, GEIJSEN A J M R, et al. Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: Results from the FOCUS consortium[J]. The American Journal of Clinical Nutrition, 2021, 113（6）: 1 468-1 481.
[44] LAWSON K A, WRIGHT M E, SUBAR A, et al. Multivitamin use and risk of prostate cancer in the national institutes of health-AARP diet and health study[J]. Journal of the National Cancer Institute, 2007, 99（10）: 754-764.
[45] 王庆兰, 潘岑, 邓杨清. 营养支持在恶性肿瘤放疗患者中的应用进展[J]. 中国医药导报, 2022, 19（8）: 35-38, 47.
[46] 田宏, 李娓, 李慧婷, 等. 肿瘤病人特殊医学用途配方食品的研究进展[J]. 价值工程, 2017, 36（14）: 231-233.
[47] FEIJ P M, RODRIGUES V D, VIANA M S, et al. Effects of ω-3 supplementation on the nutritional status, immune, and inflammatory profiles of gastric cancer patients: A randomized controlled trial[J]. Nutrition, 2019, 61: 125-131.
[48] 文星, 曾翔, 唐华. β-羟基-β-甲基丁酸治疗肿瘤恶病质的研究进展[J]. 医学综述, 2019, 25（3）: 459-463, 469.
[49] AJOUZ H, GARCIA A M, BARBUL A. Role of β-Hydroxy β-Methylbutyrate （HMB） in cancer cachexia/sarcopenia[J]. Journal of Nutritional Oncology, 2019, 4（1）: 1-8.
[50] 田林, 陈锦瑶. β-羟基-β-甲基丁酸钙安全性和有效性研究进展[J]. 食品安全质量检测学报, 2021, 12（16）: 6 565-6 572.
[51] 杨柳青, 王林, 田红梅, 等. HMB对Ⅰ～Ⅲ期老年结肠癌患者术后疲劳状态及生活质量影响[J]. 肿瘤代谢与营养电子杂志, 2022, 9（2）: 229-233.
[52] 郭志学, 宋新梅, 刘博, 等. Omega-3多不饱和脂肪酸、精氨酸和谷氨酰胺的胃肠外营养支持治疗对肝癌患者术后效果分析[J]. 河北医药, 2019, 41（6）: 847-850.
[53] 熊永强, 郭云童, 陈浩, 等. 谷氨酰胺对结肠癌患者术后肠黏膜屏障功能的影响[J]. 肿瘤代谢与营养电子杂志, 2018, 5（1）: 53-58.
[54] NAGANUMA A, HOSHINO T, OHNO N, et al. β-Hydroxy-β-methyl butyrate/L-arginine/L-glutamine supplementation for preventing hand: Foot skin reaction in sorafenib for advanced hepatocellular carcinoma[J]. Vivo, 2019, 33（1）: 155-161.
[55] KRAFT M, KRAFT K, GARTNER S, et al. L-Carnitine-supplementation in advanced pancreatic cancer （CARPAN）: A randomized multicentre trial[J]. Nutrition Journal, 2012, 11（1）: 52-58.
[56] 陈晓莉, 饶辉, 郎春辉, 等. 益生菌联合益生元预防宫颈癌患者急性放射性肠炎的研究[J]. 肿瘤代谢与营养电子杂志, 2022, 9（3）: 340-344.